ARNA Panacea

ARNA Panacea

Created using Figma
Created using Figma
ARNA Panacea by design is a platform which allows not only processing of clinical trials data but also support for researchers during R&D phase and marketplace for all types of market participants involved in clinical trials as well as direct sales of final biotech products to customers (patients).
Risk: High
Dec 15, 2017
Feb 10, 2018
100% completed
$329 227
100% goal completed
past
Sep 21, 2017
Dec 3, 2017
100% completed
$52 552
cap
goal
7% goal completed
Goal 3 333.00 ETH
Cap 130 000.00 ETH
past
  • 1 ARNA
    =
    0.003333 USD
Token Details
Ticker
ARNA
Accepted Currencies
ETH
Company Details
Registered Country
Russia
Additional Details
Platform
Ethereum
Categories
Platform, Health

About ARNA Panacea

ARNA Genomics is an innovative biotechnological company, launched on the basis of the
scientific and research laboratory and a team of like-minded people, engaged in development and research of early detection methods of oncological diseases with the purpose of launch of diagnostic tests for early cancer detection on the global market.

Our mission is to increase the life expectancy and significantly reduce human mortality by means of global market launch of most recent, unique in efficiency methods of screening (screening study with the purpose of detection and prevention of disease development in population), diagnostics (correct diagnosing) and monitoring of treatment process of oncological diseases.

ARNA Genomics company has discovered a technology which allows to develop tests for different types (nosologies) of cancer. Besides, the company has also developed a unique concept of blockchain based ecosystem, which will be used as an instrument to support R&D and implementation of biotechnologies worldwide.

We have completed R&D for the first product based on our technology – breast cancer test.

Colon cancer test is currently in R&D stage. Besides, we are currently developing a blockchain platform solution – ARNA Panacea, which will soon allow to change the world by making launch of new biotech solutions against cancer much easier and faster.

Features

ARNA Panacea is platform which allows not processing of clinical trials data and also support for researchers during R&D phase and marketplace for all types of market participants involved in clinical trials as well as direct sales of final biotech products to customers (patients).

The platform’s initial purpose is to gain, store and analyze information on all the methods of cancer detection and treatment from all over the world. This would allow researchers getting more accurate and precise knowledge on the subject on one hand, and on the other — will provide trustable and accessible proof to all market participants on research results conducted throughout their lifecycle.

ARNA Panacea Roadmap

  • 2013

  • ARNA Genomics was established
  • 2014

  • Seed round; Development of ARNA-Thermometr, a test for the presence of oncological diseases; “Know-how” objects formalization
  • 2015

  • Development of ARNA Breast Cancer — a high-precision test for early detection of breast cancer
  • 2016

  • Development of ARNA Colon Cancer; ARNA BC development is completed; Beginning of laboratory tests of ARNA BC; Submission of patent application No 1
  • Read More
  • 2017

  • End of laboratory tests of ARNA BC; Start of ARNA BC clinical research jointly with Sechenov University; Submission of application of Patent Cooperation Treaty No 1; Token Distribution Event
  • 2018

  • - Opening of the office and the 1st laboratory unit in the USA.- Submission of application of Patent Cooperation Treaty No 2 and 3.- Agreement of the regulatory strategy for ARNA BC. Launch of clinical research No 1 in the USA with FDA.- ARNA CC development is completed, starting laboratory research.- ARNA Panacea – launch of the beta version of blockchain-ecosystem, basic documentation for develop
  • 2019

  • - Using of ARNA Panacea’s blockchain ecosystem by interested market players (regulators, investors, users, etc.)- Start of development: ARNA Lung, ARNA Liver, ARNA Pancreas;- ARNA BC’s entry into the US market;- Clinical trials in China;- National phases: USA, China, India, EU, UK, Israel, Brazil;- Seed round B;- Receiving the first revenue.

Activity

Activity:
505
VERY HIGH
Posts:
725
HIGH
Views:
10 567
VERY HIGH
Activity:
505
VERY HIGH
Merit:
500
VERY HIGH
Posts:
1 112
VERY HIGH
Views:
16 239
VERY HIGH
Users:
190
MEDIUM
Posts:
92
LOW
Followers:
21 375
VERY HIGH
Likes:
21 210
VERY HIGH
Rating:
4.30
HIGH
Followers:
426
VERY LOW
Tweets:
142
MEDIUM
30 Days Growth:
-4
Members:
1 426
LOW
30 Days Growth:
-20

ARNA Panacea Team

Verified 0%

Attention. There is a risk that unverified members are not actually members of the team

Egor Melnikov
Founder & CEO
unverified
George Nikitin
COO & co-founder
unverified
Anatoliy Melnikov
Scientific supervisor and creator of the ARNA BC t...
unverified
Ilya Senechkin
PhD, Wageningen University, Netherlands
unverified
Sergey Chernyshev
Ph.D., molecular biotechnologist
unverified
Magomed Chatuev
Software architect and developer
unverified
Sergey Dolgachev
Entrepreneur and co-owner
unverified
ALEXANDER MAZALETSKI...
Software Architect
unverified
VLADIMIR SAVANOVICH
Co-founder, Head of Investor Relations
unverified

Advisors

Verified 0%

Attention. There is a risk that unverified members are not actually members of the team

DMITRY KULISH
Advisor
unverified
PD DR. SOENKE BARTLI...
Advisor
unverified
SERGEY BOROVSKIY
Advisor
unverified

2 ICO

$380 879

ALEX KOSIK
Advisor
unverified
DMITRY GRIGORIEV
Advisor
unverified
MIKHAIL GROUBMAN
Advisor
unverified
MARINA SEKACHEVA
Advisor
unverified
ILYA N. CHISTYAKOV
Advisor
unverified
ED KANALOSH
Advisor
unverified

ARNA Panacea Last News

3.24
risky+
5.0 12
ICO Profile Vision Activity Potential Product Team

ARNA Panacea Reviews

bitcoinexchangeguide.com
reviews

ARNA Genomics is developing a blockchain technology called ARNA Panacea. That blockchain features a data storage system and ecosystem catered towards the world of medical research. Researchers are incentivized to share data with the platform, while regulators can view data as evidence that a particular trial or test was successful.

ARNA Genomics, prior to creating this blockchain platform, has been heavily involved with creating early detection tests for cancer – including breast cancer tests. ARNA Panacea is designed to feature research from its early cancer detection tests – as well as the tests created by medical research companies worldwide.

Read More
  • Because there may be time differences in information updates, accurate information about each ICO project should be verified through its official website or other communication channels.
  • This information is not a suggestion or advice on investing in ICO funding. Please thoroughly investigate the relevant information yourself and decide on ICO participation.
  • If you think there are issues or problems to be corrected on this content, or if you would like to submit your own ICO project to be listed, Please email us.
Please read the disclaimer and risk warning. Show disclaimer and risk warning.
Planning an ICO? We can help with a wide range of support for all stages of your ICO